SHANGHAI (Reuters) – A crackdown on corruption and pricing in China’s fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of easy growth in the country may be over.
A Reuters’ analysis of more than 60...
A bitter pill as China crackdowns squeeze pharma margins
Sunday, May 25, 2014
A bitter pill as China crackdowns squeeze pharma margins
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment